1. Unraveling the mysteries of serum albumin—more than just a serum protein
   Angelica M. Merlot et al, 2014, Front. Physiol. CrossRef
2. Human Serum Albumin and HER2-Binding Affibody Fusion Proteins for Targeted Delivery of Fatty Acid-Modified Molecules and Therapy
   Daoyuan Dong et al, 2016, Mol. Pharmaceutics CrossRef
3. Review of Neurosurgical Fluorescence Imaging Methodologies
   Brian W Pogue et al, 2010, IEEE J. Select. Topics Quantum Electron. CrossRef
4. Interaction of Lipoplex with Albumin Enhances Gene Expression in Hepatitis Mice
   Naoki Yoshikawa et al, 2020, Pharmaceutics CrossRef
5. Efficacy and tolerability of an aminopterin–albumin conjugate in tumor-bearing rats
   Paul Kremer et al, 2002, Anti-Cancer Drugs CrossRef
6. Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma
   Andreas Wunder et al, 1998, Int. J. Cancer CrossRef
7. Polymer Therapeutics: Concepts and Applications
   Rainer Haag et al, 2006, Angew. Chem. Int. Ed. CrossRef
8. Polymere Therapeutika: Konzepte und Anwendungen
   Rainer Haag et al, 2006, Angew. Chem. CrossRef
9. Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
   C. Bolling et al, 2006, Invest New Drugs CrossRef
10. Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent
    Mark S. Dennis et al, 2007, Cancer Res CrossRef
11. Analysis of Immediate Stress Mechanisms upon Injection of Polymeric Micelles and Related Colloidal Drug Carriers: Implications on Drug Targeting
    Tobias Miller et al, 2012, Biomacromolecules CrossRef
12. Prodrug Strategies in Anticancer Chemotherapy
    Felix Kratz et al, 2008, ChemMedChem CrossRef
13. Learning from nature: the role of albumin in drug delivery
    Maria J Matos, 2018, Future Medicinal Chemistry CrossRef
14. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles
    Sanyog Jain et al, 2011, Nanomedicine CrossRef
15. In vitroandin vivoEfficacy of Acid-Sensitive Transferrin and Albumin Doxorubicin Conjugates in a Human Xenograft Panel and in the MDA-MB-435 Mamma Carcinoma Model
    Felix Kratz et al, 2000, Journal of Drug Targeting CrossRef
16. Octyl syringate is preferentially cytotoxic to cancer cells via lysosomal membrane permeabilization and autophagic flux inhibition
    Minho Won et al, 2021, Cell Biol Toxicol CrossRef
17. The Role of Extracellular Factors in Human Metastatic Chordoma Cell Growth In Vitro
    Elena Ostroumov et al, 2007, Spine CrossRef
18. Direct Convective Macromolecule Delivery
    , 1999 CrossRef
19. Serum Proteins as Drug Carriers of Anticancer Agents: A Review
    Felix Kratz et al, 1998, Drug Delivery CrossRef
20. A novel D-glyceraldehyde-3-phosphate binding protein, a truncated albumin, with D-glyceraldehyde-3-phosphate dehydrogenase inhibitory property
    Amrita Roy et al, 2009, IUBMB Life CrossRef
21. Anticancer Drug Conjugates with Macromolecular Carriers
    F Kratz et al, 2001 CrossRef
22. Intraoperative Fluorescence Staining of Malignant Brain Tumors Using 5-Aminofluorescein-Labeled Albumin
    Paul Kremer et al, 2009 CrossRef
23. Native albumin for targeted drug delivery
    Elena Neumann et al, 2010, Expert Opinion on Drug Delivery CrossRef
24. Harnessing molecular recognition for localized drug delivery
    Renjie Liu et al, 2021, Advanced Drug Delivery Reviews CrossRef
25. Stability, accumulation and cytotoxicity of an albumin-cisplatin adduct
    Charlotte Møller et al, 2010, Metallomics CrossRef
26. Combination therapy with the albumin-binding prodrug of doxorubicin (INNO-206) and doxorubicin achieves complete remissions and improves tolerability in an ovarian A2780 xenograft model
    Felix Kratz et al, 2012, Invest New Drugs CrossRef
27. Coordination conjugates of therapeutic proteins with drug carriers: A new approach for versatile advanced drug delivery
    Zdeněk Kejík et al, 2011, Bioorganic & Medicinal Chemistry Letters CrossRef
28. Determination of the binding sites for oxaliplatin on insulin using mass spectrometry-based approaches
    Charlotte Møller et al, 2011, Anal Bioanal Chem CrossRef
29. Serum Proteins as Drug Carriers of Anticancer Agents
    Felix Kratz et al, 2011 CrossRef
30. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain
    Mischa R. Müller et al, 2012, mAbs CrossRef
31. Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model
    H. Misak et al, 2013, Journal of Biotechnology CrossRef
32. Cell-penetrating albumin conjugates for enhanced doxorubicin delivery
    Qianqian Guo et al, 2013, Polym. Chem. CrossRef
33. Fusion Proteins for Half‐Life Extension
    Stefan R. Schmidt, 2013 CrossRef
34. Albumin-based nanocomposite spheres for advanced drug delivery systems
    Heath E. Misak et al, 2014, Biotechnology Journal CrossRef
35. Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis
    Andreas Wunder et al, 2003, J Immunol CrossRef
36. Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag
    Anke Hahnenkamp et al, 2014, Journal of Controlled Release CrossRef
37. Catabolism of 64Cu and Cy5.5-labeled human serum albumin in a tumor xenograft model
    Choong Mo Kang et al, 2016, Amino Acids CrossRef
38. Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer
    Sunhui Chen et al, 2017, J. Mater. Chem. B CrossRef
39. Dual-Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug-Resistant Cancer Therapy
    Pengfei Zhao et al, 2017, Adv. Funct. Mater. CrossRef
40. Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates
    Maria J. Matos et al, 2018, Chem. Eur. J. CrossRef
41. Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy
    Yujie Zhang et al, 2018, Biomaterials CrossRef
42. Roles of Albumin-Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery
    Pengfei Zhao et al, 2018, ChemBioChem CrossRef
43. Glioma targeted delivery systems
    Shanshan Wang et al, 2019 CrossRef
44. The intra-brain distribution of brain targeting delivery systems
    Xiaopeng Mo et al, 2019 CrossRef
45. Electrospun nanofibers for drug delivery
    Ramazan Asmatulu et al, 2019 CrossRef
46. The nanoparticle-facilitated autophagy inhibition of cancer stem cells for improved chemotherapeutic effects on glioblastomas
    Lu Lu et al, 2019, J. Mater. Chem. B CrossRef
47. Development of a Novel Imaging Agent for Determining Albumin Uptake in Solid Tumors
    S. Daum et al, 2019, Nucl Med Mol Imaging CrossRef
48. In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer
    Inés Luis de Redín et al, 2020, Drug Deliv. and Transl. Res. CrossRef
49. Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
    Guillermo Moreno‐Alcántar et al, 2023, Angewandte Chemie CrossRef
50. Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
    Guillermo Moreno‐Alcántar et al, 2023, Angew Chem Int Ed CrossRef
51. Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenograftsin vivo
    Angelika M. Burger et al, 2001, Int. J. Cancer CrossRef
52. Pharmacological aspects of targeting cancer gene therapy to endothelial cells
    H.H. Sedlacek, 2001, Critical Reviews in Oncology/Hematology CrossRef
53. Mammographic compression: a force to be reckoned with
    , 1999, Br J Cancer CrossRef
54. LETTERS TO THE EDITOR
    Gerd Stehle et al, 1998, Annals of Surgery CrossRef
55. Magnetic Resonance Imaging of Nude Mice With Heterotransplanted High-Grade Squamous Cell Carcinomas
    F. KIESSLING et al, 2002, Investigative Radiology CrossRef
56. An overview of Albumin - Based Nanoparticles: Targeted Precision in Cancer Chemotherapy
    null Prema Rathinam et al, 2023, ijamscr CrossRef
57. Cathepsin B Processing Is Required for the In Vivo Efficacy of Albumin–Drug Conjugates
    Barbara Bernardim et al, 2024, Bioconjugate Chem. CrossRef
58. Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy
    Ella N. Hoogenboezem et al, 2024, Nat Commun CrossRef
59. Design, optimization, and evaluation of methotrexate loaded and albumin coated polymeric nanoparticles
    Gaurav Tiwari et al, 2024, Journal of Biomaterials Science, Polymer Edition CrossRef
60. Overcoming therapeutic limitations in glioblastoma treatment: A nanocomposite inducing ferroptosis and oxeiptosis via Photodynamic therapy
    Lei Xu et al, 2024, Chemical Engineering Journal CrossRef
61. Fusion Proteins: Current Status and Future Perspectives
    Stefan R. Schmidt, 2024 CrossRef